Rh Factor and RhoGAM in Pregnancy: Who Needs It, When, and Why It Protects Your Baby
Rh factor is a protein on red blood cells; if you are Rh-negative and your baby is Rh-positive, your immune system can form antibodies that threaten this or future pregnancies. Rho(D) immune globulin (brand names include RhoGAM) prevents this by blocking your immune response when given at recommended times in pregnancy and after delivery.
This guide explains how and when Rh status is checked, who needs Rho(D) immune globulin and when, what to do after bleeding or procedures, how safe the medication is, what happens at delivery, and how care changes if your antibody screen is already positive. It also clarifies how Rh status and Rho(D) immune globulin intersect with delayed cord clamping and private cord blood or tissue banking so you can make informed, guideline-aligned choices with your care team.
Key Takeaways
- If you are Rh-negative and not yet sensitized, standard care is Rho(D) immune globulin at 28 weeks and again within 72 hours after delivering an Rh-positive baby.
- You also need Rho(D) immune globulin after potential sensitizing events such as bleeding, miscarriage, ectopic pregnancy, abdominal trauma, or procedures like amniocentesis or CVS.
- Safety data show Rho(D) immune globulin is well tolerated; serious reactions are rare, and it is not given to people who are already alloimmunized to D.
- At delivery, the baby’s blood type is tested from cord blood and the maternal blood may be tested for fetomaternal hemorrhage to determine if extra doses are needed.
- If your antibody screen is already positive, you do not receive Rho(D) immune globulin; instead, pregnancy is monitored for fetal anemia and treated if needed.
- Delayed cord clamping is compatible with most births and with cord blood banking, though it can reduce collection volume; planning with your team helps balance both goals.
- Being Rh-negative or receiving Rho(D) immune globulin does not prevent private cord blood or tissue banking.
What is the Rh factor, and why does it matter in pregnancy?
The Rh factor (specifically the D antigen) is a protein on red blood cells; people either have it (Rh-positive) or do not (Rh-negative). If an Rh-negative pregnant person carries an Rh-positive fetus, exposure to fetal red cells can trigger anti-D antibodies that may destroy fetal red cells in this or future pregnancies.
This immune process is called Rh alloimmunization and can cause hemolytic disease of the fetus and newborn, which ranges from mild jaundice to severe anemia and hydrops. Preventing maternal sensitization with Rho(D) immune globulin has dramatically lowered the risk of Rh-related hemolytic disease in countries where it is routinely used.
How and when will my care team check my blood type and antibody screen?
Your ABO/Rh blood type and an antibody screen are checked at the first prenatal visit, and the antibody screen is typically repeated around 28 weeks before giving Rho(D) immune globulin if you are Rh-negative. After birth, the baby’s blood type is tested from the umbilical cord to decide if you need a postpartum dose.
If an antibody screen ever shows anti-D or another red cell antibody, your care plan changes from prevention to monitoring for fetal or newborn effects. Testing may also be repeated after any event that could cause fetomaternal hemorrhage, such as bleeding or certain procedures.
Who needs Rho(D) immune globulin (RhoGAM), and at what points in pregnancy?
If you are Rh-negative and not already sensitized (antibody screen negative), standard care is a prophylactic dose of Rho(D) immune globulin at about 28 weeks and another dose within 72 hours after delivery if your newborn is Rh-positive or if the baby’s Rh type is unknown. You also receive a dose after any potential sensitizing event during pregnancy.
This schedule protects you against forming anti-D antibodies late in pregnancy and around delivery, when fetal cells are most likely to enter your circulation. Your clinician will confirm timing and dose based on your situation and any tests that estimate the amount of fetomaternal hemorrhage.
Which situations require an extra dose (bleeding, procedures, trauma, miscarriage/ectopic, or multiples)?
Give Rho(D) immune globulin to unsensitized, Rh-negative patients after events that can mix fetal and maternal blood, including vaginal bleeding, miscarriage, ectopic pregnancy, uterine aspiration, abdominal trauma, or procedures like amniocentesis, chorionic villus sampling (CVS), or external cephalic version. Typical doses are 50 micrograms before 12 weeks if available or 300 micrograms at or after 12 weeks; dosing can be increased if tests show a large fetomaternal hemorrhage.
| Scenario | Who should receive RhIG | Typical dose | Timing | Notes/testing |
|---|---|---|---|---|
| Routine prophylaxis at 28 weeks | Rh-negative, antibody screen negative | 300 micrograms IM/IV | At ~28 weeks after repeat antibody screen | Covers the remainder of pregnancy |
| After delivery | Rh-negative, newborn Rh-positive or unknown | 300 micrograms IM/IV (adjust if large FMH) | Within 72 hours of birth | Use fetomaternal hemorrhage testing (rosette/Kleihauer–Betke/flow cytometry) to determine if extra vials are needed |
| Bleeding or pregnancy loss <12 weeks (miscarriage, ectopic, uterine aspiration) | Rh-negative, unsensitized | 50 micrograms IM/IV if available; 300 micrograms acceptable | Within 72 hours of event | Dose reflects small fetal blood volume before 12 weeks |
| Bleeding ≥12 weeks, placenta previa/abruption, abdominal trauma | Rh-negative, unsensitized | 300 micrograms IM/IV (increase if large FMH) | Within 72 hours of event | Consider repeat dosing if ongoing bleeding; quantify FMH if significant |
| Invasive procedures (CVS, amniocentesis) or external cephalic version | Rh-negative, unsensitized | 300 micrograms IM/IV | Within 72 hours of procedure | Provider may obtain antibody screen before dosing |
| Multifetal gestation delivery (twins+) | Rh-negative, newborn(s) Rh-positive or unknown | 300 micrograms IM/IV (adjust as needed) | Within 72 hours of birth | Higher FMH risk; use FMH testing to guide additional dosing |
One 300 microgram dose protects against approximately 30 mL of fetal whole blood (about 15 mL of fetal red cells) entering the maternal circulation; larger hemorrhages need proportionally more. Your team may use a screening rosette test followed by a Kleihauer–Betke stain or flow cytometry to calculate extra dosing.
How safe is RhoGAM, and what side effects or contraindications should I know about?
Rho(D) immune globulin has a long record of safety in pregnancy, with the most common side effects being soreness at the injection site, mild fever, or headache. Serious reactions are rare; those with a history of severe hypersensitivity to human immune globulin or IgA deficiency with anti-IgA antibodies require special caution.
Rho(D) immune globulin is made from screened human plasma and is not given to people who are already alloimmunized to D or to those who are Rh-positive. It is considered compatible with breastfeeding, and postpartum recipients can continue nursing.
What happens at delivery—how is my baby’s blood type tested, and do I need another shot?
After birth, your baby’s blood type is tested—usually from umbilical cord blood—to determine if you need a postpartum Rho(D) immune globulin dose. If your baby is Rh-positive (or the type is unknown), you should receive Rho(D) immune globulin within 72 hours; if your baby is Rh-negative, no postpartum dose is required.
Because delivery is when most fetomaternal hemorrhage occurs, your team may perform a fetomaternal hemorrhage assessment to see if more than one vial is needed. Getting the dose as soon as possible is ideal, but some benefit persists if it is given later than 72 hours.
What if my antibody screen is already positive—how is Rh alloimmunization managed and monitored?
If your antibody screen already shows anti-D, you do not receive Rho(D) immune globulin; instead, care shifts to monitoring for fetal anemia and planning treatment if needed. Management typically includes confirming the fetus’s RhD status (by partner testing or cell-free DNA) and following maternal antibody titers.
When titers reach a critical level or there is a concerning history, specialists use middle cerebral artery Doppler ultrasound to screen for fetal anemia and, if indicated, treat with intrauterine transfusion or adjust delivery timing. Newborns are monitored for anemia and jaundice, with treatments such as phototherapy or transfusion as needed.
Does Rh status or RhoGAM affect delayed cord clamping or cord blood/tissue banking?
Being Rh-negative or receiving Rho(D) immune globulin does not prevent delayed cord clamping or private cord blood/tissue banking. However, delayed cord clamping can reduce the volume available for cord blood collection, so planning and clear communication help balance both goals.
Standard practice is to clamp the umbilical cord after at least 30–60 seconds for most vigorous infants, then collect cord blood from the placental end if banking is planned. Your obstetric team and your cord blood bank kit instructions can usually accommodate both delayed clamping and collection when feasible.
Frequently Asked Questions
Can I skip the 28-week shot if my partner is confirmed Rh-negative?
If paternity is certain and your partner is truly Rh-negative, the fetus will be Rh-negative and you would not be at risk for Rh incompatibility. Some clinicians still prefer routine prophylaxis unless partner testing is documented, given the possibility of lab or documentation errors; discuss your preferences and local practice with your clinician.
What if I miss the 72-hour window after delivery?
You should receive Rho(D) immune globulin as soon as possible, with 72 hours as the ideal target. If that window is missed, there may still be benefit from giving it later, and some sources note effectiveness even when administered beyond several days postpartum; contact your obstetric clinician promptly to arrange dosing.
Does Rho(D) immune globulin affect breastfeeding?
No. Rho(D) immune globulin is considered compatible with breastfeeding, and you can continue nursing after receiving it. The medication does not harm the infant when used as recommended.
Will I need Rho(D) immune globulin in every pregnancy?
If you are Rh-negative and remain unsensitized, prophylaxis is recommended in each pregnancy at 28 weeks, after delivery of an Rh-positive infant, and after any sensitizing events. If you ever become alloimmunized (antibody screen positive), you will not receive Rho(D) immune globulin and your care team will shift to monitoring and treatment.
Can I have delayed cord clamping and still store cord blood?
Yes—many families do both. Delayed cord clamping can lower the volume of cord blood collected, but with planning and a skilled team, a collection that meets your bank’s requirements is often still possible.
Sources
- American College of Obstetricians and Gynecologists (ACOG) — The Rh Factor: How It Can Affect Your Pregnancy
- MedlinePlus (U.S. National Library of Medicine) — Rho(D) immune globulin injection
- StatPearls (NCBI Bookshelf) — Rho(D) Immune Globulin
- American College of Obstetricians and Gynecologists (ACOG) — Delayed Umbilical Cord Clamping After Birth (Committee Opinion No. 814)
- StatPearls (NCBI Bookshelf) — Kleihauer Betke Test
- MedlinePlus (U.S. National Library of Medicine) — Rh incompatibility
- Royal College of Obstetricians and Gynaecologists (RCOG) — The management of women with red cell antibodies during pregnancy (Green-top Guideline No. 65)
- Drugs and Lactation Database (LactMed), NCBI Bookshelf — Rho(D) Immune Globulin
The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.